Skip to main content

Peer Review reports

From: Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma

Original Submission
19 Jan 2022 Submitted Original manuscript
2 Feb 2022 Reviewed Reviewer Report
6 Feb 2022 Reviewed Reviewer Report
7 Feb 2022 Reviewed Reviewer Report
7 Feb 2022 Reviewed Reviewer Report
13 Feb 2022 Reviewed Reviewer Report - Ratnakar Singh
16 Mar 2022 Author responded Author comments - Ziyue Gu
Resubmission - Version 2
16 Mar 2022 Submitted Manuscript version 2
17 Mar 2022 Reviewed Reviewer Report
17 Mar 2022 Reviewed Reviewer Report
19 Mar 2022 Reviewed Reviewer Report
30 Mar 2022 Reviewed Reviewer Report
5 Apr 2022 Reviewed Reviewer Report - Ratnakar Singh
6 Apr 2022 Author responded Author comments - Ziyue Gu
Resubmission - Version 3
6 Apr 2022 Submitted Manuscript version 3
8 Apr 2022 Author responded Author comments - Ziyue Gu
Resubmission - Version 4
8 Apr 2022 Submitted Manuscript version 4
Publishing
11 Apr 2022 Editorially accepted
12 May 2022 Article published 10.1186/s12916-022-02373-6

You can find further information about peer review here.

Back to article page